Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2011 Q1- Text added to 2011 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
accrual, adult, aforementioned, age, alfa, boceprevir, bringing, CHC, chronic, conclusion, coupon, de, debit, decided, disease, Eyetech, FDA, Food, forfeited, forward, genotype, Incivek, infection, interferon, liver, older, outplacement, peginterferon, point, responded, reversal, ribavirin, specific, subsidiary, telaprevir, therapy, unchanged, untreated
Removed:
ability, beginning, book, classification, collectively, companyo, component, consummated, enroll, facilitate, facility, filero, filerx, flow, fully, immaterial, influence, intended, meeting, netted, OSI, outlined, ownership, pediatric, proper, qualified, recurring, shareholder, treated, withholding
Valuein 2011 Q1 filing- Value in 2011 Q2 filing
Original filings
Filing view